Category Archives: Biotechnology

The stock market performed reasonably well on Friday, sending major benchmarks to gains of 0.25% to 0.5% on the day. Favorable news from the U.S. economy outweighed any concerns about geopolitical events occurring this weekend, including the much-awaited final phase of the French elections. The Dow regained the 21,000 level, and the S&P 500 finished just below the 2,400 mark. But some stocks missed out on the rally, and Puma Biotechnology (NASDAQ:PBYI), Trex (NYSE:TREX), and National CineMedia (NASDAQ:NCMI) were among the worst performers on the day. Below, we'll look more closely at these stocks to tell you why they did so poorly. Shares of Puma Biotechnology fell 16% after the biotech company said in an SEC filing that an executive in charge of regulatory affairs and project management would resign from the company effective May 15. The filing said that Dr. Robert Charnas had told Puma last week about his departure, with the filing citing health reasons for the move. Yet investors seem to be nervous about the timing, coming immediately before a key advisory panel meeting for its neratinib treatment for breast cancer. Given that neratinib has seen patients in trials report negative side effects, some investors believe that … Continue reading →

The well-known TED Talks is a clearinghouse of big thinkers and big ideas, and quite a few of them have focused on agriculture and food production over the years. Engineering Drought Resistance Jill Farrant, a Professor of molecular and cell biology at University of Cape Town, South Africa, is studying how ancient DNA can be turned on to help important food crops fight off drought. She and colleagues have been studying resurrection plants to achieve this goal. Resurrection plants are those that can undergo extreme drought without water for months or even years. Then when the next rain comes along within 12 to 48 hours the plants green up and start growing again. Farrants How We Can Make Plants Survive Without Water TED Talk featured her research into how resurrection plants work and if those special characteristics could be transferred into other plants, especially food crops. Robot Swarms Vijay Kumar, Dean of the University of Pennsylvanias School of Engineering and Applied Science, wowed his TED Talk audience with his presentation titled The Future of Flying Robots. His lab is developing autonomous flying robots that use onboard sensors, cameras, and laser scanners to map the environment it is in and avoid … Continue reading →

Post Analyst Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI) The Cerbat Gem Puma Biotechnology Inc logo Stifel Nicolaus reaffirmed their buy rating on shares of Puma Biotechnology Inc (NYSE:PBYI) in a report released on Wednesday, April 19th. They currently have a $88.00 target price on the biopharmaceutical company's stock. Puma Biotechnology (PBYI) Getting Somewhat Positive Press Coverage, Report ShowsTranscript Daily Puma Biotechnology, Inc. (PBYI) held by 19 SEC 13F Filers | Post ...Post Analyst NJ State Employees Deferred Compensation Plan Has $341000 Position in Puma Biotechnology Inc (PBYI)Markets Daily Chaffey Breeze -Bibeypost.com -Sports Perspectives all 16 news articles » Go here to see the original: Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI) - The Cerbat Gem … Continue reading →

Transcript Daily iShares NASDAQ Biotechnology Index (IBB) Receiving Very Favorable Media Coverage, Report Shows The Cerbat Gem iShares NASDAQ Biotechnology Index logo News headlines about iShares NASDAQ Biotechnology Index (NASDAQ:IBB) have trended very positive this week, AlphaOne reports. The research group, a subsidiary of Accern, identifies positive and negative ... SPC Financial Inc. Sells 2,240 Shares of iShares NASDAQ ...Transcript Daily iShares NASDAQ Biotechnology Index (IBB) Stake Increased by Ariel Capital Advisors LLCChaffey Breeze iShares NASDAQ Biotechnology Index (IBB) Getting Positive Press Coverage, AlphaOne ReportsBBNS Markets Daily -Sports Perspectives -Barron's all 39 news articles » Read the rest here: iShares NASDAQ Biotechnology Index (IBB) Receiving Very Favorable Media Coverage, Report Shows - The Cerbat Gem … Continue reading →

In a landmark ruling on March 28 2017, the Delhi High Court, in Monsanto Technology LLC & Ors v Nuziveedu Seeds Limited & Ors, gave a prima facie opinion on the patentability and enforceability of man-made DNA sequences. Although only an order at the interim stage, this is the first time an Indian court has ruled on this issue and the order itself is a lengthy one. The Delhi High Court's interim order also deals with other issues of contract law and termination and despite finding in favour of Monsanto, inter alia, on patent issues, the Court ruled against Monsanto on certain contract-related issues. The infringement suit initiated by Monsanto, covering patents, trade marks and common law rights, was against a former sub-licensee of Monsanto's Bollgard II technology. Although Indian law prevents the patenting of plants, parts thereof and essentially biological processes for the production or propagation of plants, the Court held that the legislative intent was only to prevent patents being granted on what was naturally occurring. Thus, the Delhi High Court ruled that products of biotechnological processes such as man-made DNA sequences meant for use in plants are still patentable subject matter in India. The Delhi High Court's … Continue reading →

Puma Biotechnology, Inc. (PBYI - Free Report) is expected to report first-quarter 2017 results later this month. The companys earnings track record is disappointing as it missed estimates in three of the trailing four quarters and met expectations in one. The company had an average negative surprise of 3.23% in the last four quarters. Pumas shares have outperformed the Zacks classified Medical-Biomedical and Genetics industry, year to date. Shares of the company gained 27.2% so far this year, while the industry recorded an increase of 5.5%. In the last reported quarter, Puma posted a negative surprise of 0.99%. Lets see how things are shaping up for this announcement. Factors at Play Being a development-stage company, Puma Biotech does not have any approved product in its portfolio. Thus, investor focus should remain on updates pertaining to the development of neratinib, its lead pipeline candidate. The candidate is currently under review in both the U.S. and the EU for the extended adjuvant treatment of HER2-positive early-stage breast cancer in patients who have previously been treated with Herceptin-based adjuvant therapy. Moreover, several phase II combination studies on neratinib for the treatment of breast cancer are currently underway. In Apr 2017, Puma presented encouraging … Continue reading →

BBNS Northeast Financial Consultants Inc Sells 650 Shares of iShares NASDAQ Biotechnology Index (IBB) The Cerbat Gem iShares NASDAQ Biotechnology Index logo Northeast Financial Consultants Inc cut its stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 48.1% during the first quarter, according to its most recent disclosure with the Securities and ... iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Beaumont Financial Partners LLCTranscript Daily iShares NASDAQ Biotechnology Index (IBB) Stake Maintained by Barrett Asset Management LLCSports Perspectives Stock Traders Buy Large Volume of iShares NASDAQ Biotechnology Index Call Options (IBB)Markets Daily BBNS -Chaffey Breeze -Barron's all 24 news articles » Link: Northeast Financial Consultants Inc Sells 650 Shares of iShares NASDAQ Biotechnology Index (IBB) - The Cerbat Gem … Continue reading →

TORONTO, May 1, 2017 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego, California. "We are pleased to be a contributor to this very prestigious conference," said Andrew Morris, CEO of SQI Diagnostics. "This event brings together the world's leading experts and representatives from all sectors of pharma and biotechnology drug development and gives us the opportunity to share our novel multiplexing applications in drug development testing. Over the past year, we have made significant progress in our work with our pharma and biotech customers and believeour unique productswill prove to be beneficial to our customers who are large, global pharmaceutical companies. The conference will run from May 1-3, 2017. Please stop by and visit us at booth 316. About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase … Continue reading →

SAN GABRIEL, California, May 2, 2017 /PRNewswire/ -- ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that it has appointed Summer (XiangYang) Yun as Chief Executive Officer (CEO) of its wholly-owned foreign entity, CBD Biotechnology Co., Ltd. ("XiBiDi Biotech"). XiBiDi Biotech's primary focus is online, retail and direct sales of hemp-based health products in China. Yun's initial focus will be the launch of 'CBD Magic Hemp Series' cosmetics line. He will also spearhead the Company's plan to import natural dietary supplements created using advanced extracting and purifying technologies into China. Yun is a marketing and branding executive with over 25 years of experience. Yun will report directly to CIIX's CEO Warren Wang. "I am honored to be named as CEO of CBD Biotech," says Yun. "For over 5,000 years, hemp has been cultivated and used in over 25,000 products worldwide. CIIX has a unique opportunity to become one of the first companies to offer CBD-based skin care products in China online and through established retail and direct selling channels. Through the introduction of Magic CBD Series cosmetics to China, I hope to educate consumers regarding hemp's many benefits." The CBD … Continue reading →

May 01, 2017 07:30 ET | Source: Research and Markets Dublin, May 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering. This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology. Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly … Continue reading →